Home / CANCER BUZZ Podcast

CANCER BUZZ Podcast

Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Topic

Filter By Podcast Format

 
 
 
 
 
With nearly half the patients the Baheya Foundation for Early Detection and Treatment of Breast Cancer in stage 3 or 4 of the disease, delayed diagnoses are one of the biggest challenges in oncology faced in Egypt today. This both causes patients to present for treatment in more advanced stages of the disease and contributes to a high breast cancer mortality rate in Egypt compared to other developed …
In this episode, CANCER BUZZ speaks with Jean Louise Koff, MD, MSc, associate professor of hematology and medical oncology at Winship Cancer Institute of Emory University, to discuss the impact of bispecific antibodies on cancer treatment outcomes, and the challenges and opportunities of integrating this innovative approach into community oncology practices.
As a large country, economic disparities persist as a public health issue in Brazil, with 70% of the population depending on the public health system. According to Dr. Theodora Karnakis, the aging population of patients with cancer is expected to result in a 61% increase of new cancer cases between 2020 and 2040. The type of care received depends heavily on where patients are located, due to the varying …
It is crucial that multidisciplinary cancer care teams stay informed about upcoming changes to Medicare Part D under the Inflation Reduction Act. To support this effort, the Association of Cancer Care Centers (ACCC) is committed to providing updated information on health care policy changes, ensuring that both providers and patients are aware of the financial benefits. In this episode, CANCER BUZZ …
Immunotherapy and targeted therapies have transformed the way patients are treated and allow more patients than ever before to survive stage IV diagnoses. Other key advancements in oncology being prioritized in Puerto Rico today include early detection and prevention efforts. However, a lack of education, access, and health insurance coverage often prevents community members from timely cancer …
All health systems work with limited resources to some degree. The challenge faced across the globe is finding the best way to allocate those resources to help the patient population as much as possible.
UCSF Health’s Seeking Care Patient Experience Team introduced web self-scheduling to improve fragmented workflows and streamline the process of seeking care from a cancer specialist.
CANCERBUZZ speaks with Dr. Naoto Ueno about his NOC session titled The Hawaiʻi Cancer Consortium: An Equitable Clinical Trials Initiative.
CANCERBUZZ speaks with Melanie Grant about her NOC session titled Navigating Access and Equity: Providing the Answers That Matter.
CANCERBUZZ speaks with guests at the 2024 NOC Gala event about what they are looking for at the conference.
CANCERBUZZ speaks with ACCC President Dr. Nadine Barrett about this year’s NOC theme: Realizing Innovation. Listen to what’s new in conversations and oncology education in 2024.
CANCERBUZZ speaks with ACCC President Dr. Nadine Barrett about this year’s NOC theme: Realizing Innovation. Listen to what’s new in conversations and oncology education in 2024.
CANCERBUZZ speaks with ACCC’s Immediate Past President Dr. Olalekan Ajayi about the international panel held at NOC this year, where cancer care providers from around the world share and learn from common challenges and best practices.
CANCERBUZZ speaks with Magbis Nunez Love about her NOC session titled Renacer: Culturally Tailored, Patient-Centered Survivorship Care Improves Access and Outcomes.
Discussions from the ACCC 50th AMCCBS held from February 28 to March 1, 2024, were used to develop the 2024 Trending Now in Cancer Care Part 1 and Part 2 reports.
In this episode, CANCER BUZZ speaks with Jeff Sharman, MD, medical director of hematology research, US Oncology, and director of research, Willamette Valley Cancer Institute, about the role of biomarker testing in guiding treatment decisions and how evidence-based management of treatment-related adverse events can serve this patient population.
Designing a health equity playbook starts with a deep understanding of the patients you serve. Successful playbooks have components that build on the patient experience, the protocols that are in place to ensure the cancer program is meeting the unique needs of all its patients, and staff education and and training on how to best serve those different patient populations.
In this episode, CANCER BUZZ speaks with Nirav Shah, MD, MSHP, associate professor of medicine at Medical College of Wisconsin and Kirollos Hanna, PharmD, BCOP, PCOP, FACCC, assistant professor of pharmacy at Mayo Clinic and director of pharmacy at Minnesota Oncology, about shared decision making in the management of relapsed or refractory mantle cell lymphoma.
In this episode, CANCER BUZZ speaks with Jacquelyn Doenges, LCSW, MSSW, CTTS, clinical oncology social worker at UT Southwestern Medical Center—Harold C. Simmons Comprehensive Cancer Center, and Linda Hutkin-Slade, MSW, LCSW, OSW-C, clinical oncology social worker at David & Donna Long Cancer Center—Sharp Grossmont Hospital, about providing optimal psychosocial support for this patient …
Female sexual dysfunction is a well-studied adverse effect of cancer treatment. Despite its prevalence, however, it remains vastly underdiagnosed and undertreated in oncology patients, with providers inadequately addressing sexual function before, during, and after treatment.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.